Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification.
Am Heart J 2017 Nov 10;193:95-103. Epub 2017 Aug 10.
Division of Cardiology, Detroit Medical Center, Wayne State University, Detroit, MI. Electronic address:
Background: The recommendation for statins in primary atherosclerotic cardiovascular disease (ASCVD) prevention begins with risk estimation using the pooled cohort equation (PCE). However, treatment decisions may still remain uncertain after PCE-based assessment. We therefore developed a simple biomarker score that could supplement decision making. Read More